- In July 2024, Bon Secours Mercy Health (BSMH) and Koninklijke Philips N.V. have announced a multi-year collaboration to enhance patient monitoring across BSMH’s 49 hospitals. This partnership aims to reduce staff burdens by integrating innovative monitoring technologies, allowing clinicians to focus more on patient care. Implementation will begin over the next three years
- In January, SCHILLER AG has launched the CARDIOVIT FT-2, an innovative ECG device designed to meet the rigorous demands of hospital environments. Featuring a hygienic 15" multi-touch display, enhanced cybersecurity, and extensive connectivity options, it is the first mobile electrocardiograph from SCHILLER to offer an optional thermal printer. This advancement not only elevates patient care through improved diagnostics but also strengthens SCHILLER's position in the competitive healthcare market, reinforcing its commitment to innovation and quality
- In April 2023, Koninklijke Philips N.V. joins forces with AWS to bring Philips HealthSuite Imaging PACS to the cloud and advance AI-enabled tools in support of clinicians. This partnership enables Philips to leverage AWS's robust cloud infrastructure for scalability, reliability, and security, while integrating advanced AI capabilities to support clinicians. The cloud-based platform allows for greater flexibility and accessibility, improving workflow efficiency and diagnostic accuracy
- In March 2022, Cardioline S.P.A. France participated in the PariSanté Campus project, collaborating with startups and companies across France and Europe to advance digital healthcare. This initiative aimed to shape the future of healthcare technology, fostering innovation and improving patient care through collective efforts in the digital health sector
- In February 2021, A.M.P.S. LLC and Cardioline S.P.A. announced a partnership to provide joint solutions in the clinical trials market. This collaboration combined A.M.P.S.’s software analytics with Cardioline’s high-performance devices, creating an end-to-end solution for clinical trial companies. Both organizations aimed to enhance functionality and offer new options in this growing market
